Integra Lifesciences shares received an average 12-month price target of $61 from brokers that have covered the stock in the last year, according to a Sleek Money report.
↧
Integra Lifesciences shares received an average 12-month price target of $61 from brokers that have covered the stock in the last year, according to a Sleek Money report.